Carregant...

Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma

B-cell non-Hodgkin lymphoma (B-NHL) is a group of heterogeneous disease which remains incurable despite developments of standard chemotherapy regimens and new therapeutic agents in decades. Some individuals could have promising response to standard therapy while others are unresponsive to standard c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomark Res
Autors principals: Yin, Zixun, Zhang, Ya, Wang, Xin
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8278776/
https://ncbi.nlm.nih.gov/pubmed/34256851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00309-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!